DFDA

Open Surgical Revascularization

Treatment for Vascular Intestinal Disorders

Effectiveness
90%
Safety Score
40%
Clinical Trials
1
Participants
8K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate
Treatment Duration
Single procedure, long-term monitoring
Evidence Quality
MODERATE
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$800
Side Effect Mgmt:$1,000
Total Annual:$1,900
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
ICER
$95,000/QALY
QALYs Gained
2.2
Outcome-Based Costs
Cost per Responder
$2,111
Cost per Remission
$2,235
Comparison vs Endovascular Revascularization
Cost Difference
+$15,000/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Open Surgical Revascularization Outcomes

for Vascular Intestinal Disorders

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+85%
Common Side Effects
Surgical site infection
+10%
Bleeding
+7%
Myocardial infarction
+5%
Stroke
+2%
Renal failure
+3%

Sources:

elsevierpure.com
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
1 completed trial for Open Surgical Revascularization in Vascular Intestinal Disorders

Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer

NCT05116696COMPLETED
View Study
836 participants
OBSERVATIONAL
Belgrade, Serbia
Started: Mar 1, 2021